These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26101933)

  • 1. Development of SHIVs with circulating, transmitted HIV-1 variants.
    Sharma A; Boyd DF; Overbaugh J
    J Med Primatol; 2015 Oct; 44(5):296-300. PubMed ID: 26101933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4-HIV-1 Envelope Interactions: Critical Insights for the Simian/HIV/Macaque Model.
    Sharma A; Overbaugh J
    AIDS Res Hum Retroviruses; 2018 Sep; 34(9):778-779. PubMed ID: 29886767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of unadapted, pathogenic SHIVs encoding newly transmitted HIV-1 envelope proteins.
    Del Prete GQ; Eilers B; Moldt B; Keele BF; Estes JD; Rodriguez A; Sampias M; Oswald K; Fast R; Trubey CM; Chertova E; Smedley J; LaBranche CC; Montefiori DC; Burton DR; Shaw GM; Markowitz M; Piatak M; KewalRamani VN; Bieniasz PD; Lifson JD; Hatziioannou T
    Cell Host Microbe; 2014 Sep; 16(3):412-8. PubMed ID: 25211081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope.
    Barnett SW; Srivastava IK; Kan E; Zhou F; Goodsell A; Cristillo AD; Ferrai MG; Weiss DE; Letvin NL; Montefiori D; Pal R; Vajdy M
    AIDS; 2008 Jan; 22(3):339-48. PubMed ID: 18195560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adapting SHIVs In Vivo Selects for Envelope-Mediated Interferon-α Resistance.
    Boyd DF; Sharma A; Humes D; Cheng-Mayer C; Overbaugh J
    PLoS Pathog; 2016 Jul; 12(7):e1005727. PubMed ID: 27399306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High throughput generation and characterization of replication-competent clade C transmitter-founder simian human immunodeficiency viruses.
    Dutta D; Johnson S; Dalal A; Deymier MJ; Hunter E; Byrareddy SN
    PLoS One; 2018; 13(5):e0196942. PubMed ID: 29758076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies.
    Mascola JR; Stiegler G; VanCott TC; Katinger H; Carpenter CB; Hanson CE; Beary H; Hayes D; Frankel SS; Birx DL; Lewis MG
    Nat Med; 2000 Feb; 6(2):207-10. PubMed ID: 10655111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of SIVmac-infected macaque monkeys against superinfection by a simian immunodeficiency virus expressing envelope glycoproteins of HIV type 1.
    Dunn CS; Hurtrel B; Beyer C; Gloeckler L; Ledger TN; Moog C; Kieny MP; Mehtali M; Schmitt D; Gut JP; Kirn A; Aubertin AM
    AIDS Res Hum Retroviruses; 1997 Jul; 13(11):913-22. PubMed ID: 9223407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with HIV-1 SF162-derived Envelope gp140 proteins does not protect macaques from heterologous simian-human immunodeficiency virus SHIV89.6P infection.
    Xu R; Srivastava IK; Kuller L; Zarkikh I; Kraft Z; Fagrouch Z; Letvin NL; Heeney JL; Barnett SW; Stamatatos L
    Virology; 2006 Jun; 349(2):276-89. PubMed ID: 16527321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AIDS preclinical vaccine development: biennial survey of HIV, SIV, and SHIV challenge studies in vaccinated nonhuman primates.
    Warren JT; Levinson MA
    J Med Primatol; 1999; 28(4-5):249-73. PubMed ID: 10593492
    [No Abstract]   [Full Text] [Related]  

  • 11. AIDS vaccine models: challenging challenge viruses.
    Feinberg MB; Moore JP
    Nat Med; 2002 Mar; 8(3):207-10. PubMed ID: 11875482
    [No Abstract]   [Full Text] [Related]  

  • 12. Rational design and in vivo selection of SHIVs encoding transmitted/founder subtype C HIV-1 envelopes.
    O'Brien SP; Swanstrom AE; Pegu A; Ko SY; Immonen TT; Del Prete GQ; Fennessey CM; Gorman J; Foulds KE; Schmidt SD; Doria-Rose N; Williamson C; Hatziioannou T; Bieniasz PD; Li H; Shaw GM; Mascola JR; Koup RA; Kwong PD; Lifson JD; Roederer M; Keele BF
    PLoS Pathog; 2019 Apr; 15(4):e1007632. PubMed ID: 30943274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection.
    Baba TW; Liska V; Hofmann-Lehmann R; Vlasak J; Xu W; Ayehunie S; Cavacini LA; Posner MR; Katinger H; Stiegler G; Bernacky BJ; Rizvi TA; Schmidt R; Hill LR; Keeling ME; Lu Y; Wright JE; Chou TC; Ruprecht RM
    Nat Med; 2000 Feb; 6(2):200-6. PubMed ID: 10655110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120.
    Veazey RS; Shattock RJ; Pope M; Kirijan JC; Jones J; Hu Q; Ketas T; Marx PA; Klasse PJ; Burton DR; Moore JP
    Nat Med; 2003 Mar; 9(3):343-6. PubMed ID: 12579198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infection of macaques with chimeric simian and human immunodeficiency viruses containing Env from subtype F.
    Kuwata T; Takemura T; Takehisa J; Miura T; Hayami M
    Arch Virol; 2002 Jun; 147(6):1121-32. PubMed ID: 12111423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lessons in nonhuman primate models for AIDS vaccine research: from minefields to milestones.
    Lifson JD; Haigwood NL
    Cold Spring Harb Perspect Med; 2012 Jun; 2(6):a007310. PubMed ID: 22675663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralizing antibodies administered before, but not after, virulent SHIV prevent infection in macaques.
    Foresman L; Jia F; Li Z; Wang C; Stephens EB; Sahni M; Narayan O; Joag SV
    AIDS Res Hum Retroviruses; 1998 Aug; 14(12):1035-43. PubMed ID: 9718118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using SHIVs to develop an anti-HIV-1 live-attenuated vaccine.
    Kuwata T; Miura T; Hayami M
    Trends Microbiol; 2001 Oct; 9(10):475-80. PubMed ID: 11597447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of HIV-specific antibody response and protection against vaginal SHIV transmission by intranasal immunization with inactivated SHIV-capturing nanospheres in macaques.
    Miyake A; Akagi T; Enose Y; Ueno M; Kawamura M; Horiuchi R; Hiraishi K; Adachi M; Serizawa T; Narayan O; Akashi M; Baba M; Hayami M
    J Med Virol; 2004 Jul; 73(3):368-77. PubMed ID: 15170630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of immune response in macaque monkeys infected with simian-human immunodeficiency virus having the TNF-alpha gene at an early stage of infection.
    Shimizu Y; Miyazaki Y; Ibuki K; Suzuki H; Kaneyasu K; Goto Y; Hayami M; Miura T; Haga T
    Virology; 2005 Dec; 343(2):151-61. PubMed ID: 16169034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.